Skip to main content
Erschienen in: World Journal of Urology 2/2018

11.11.2017 | Original Article

Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder

verfasst von: Mohammad Abufaraj, Shahrokh F. Shariat, Beat Foerster, Carmen Pozo, Marco Moschini, David D’Andrea, Romain Mathieu, Martin Susani, Anna K. Czech, Pierre I. Karakiewicz, Veronika Seebacher

Erschienen in: World Journal of Urology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the concordance rate of lymphovascular invasion (LVI) and variant histology (VH) of transurethral resection (TUR) with radical cystectomy (RC) specimens. Furthermore, to evaluate the value of LVI and VH at TUR for predicting non-organ confined (NOC) disease, lymph node metastasis, and survival outcomes.

Patients and methods

Two hundred and sixty-eight patients who underwent TUR and subsequent RC were reviewed. Logistic regression analyses were performed to evaluate the association of LVI and VH with NOC and lymph node metastasis at RC. Cox regression analyses were used to estimate recurrence-free survival (RFS) and cancer-specific survival (CSS).

Results

LVI and VH were detected in 13.8 and 11.2% of TUR specimens, and in 30.2 and 25.4% of RC specimens, respectively. The concordance rate between LVI and VH at TUR and subsequent RC was 69.8 and 83.6%, respectively. They were both associated with adverse pathological features such as lymph node metastasis and advanced stage. TUR LVI and VH were both independently associated with lymph node metastasis and TUR VH was independently associated with NOC. On univariable Cox regression analyses, TUR LVI was associated with RFS and CSS while TUR VH was only associated with RFS. Only TUR LVI was independently associated with RFS.

Conclusion

Detection of LVI is missed in a third of TUR specimens while VH seems more accurately identified. TUR LVI and VH are associated with more advanced disease and LVI predicts disease recurrence. Assessment and reporting of LVI and VH on TUR specimen are important for risk stratification and decision-making.
Literatur
1.
Zurück zum Zitat Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2016) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108CrossRefPubMed Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2016) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108CrossRefPubMed
3.
Zurück zum Zitat Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ et al (2011) Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int 107(6):898–904. http://www.ncbi.nlm.nih.gov/pubmed/21244604. Accessed 1 Mar 2017 Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ et al (2011) Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int 107(6):898–904. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​21244604. Accessed 1 Mar 2017
10.
Zurück zum Zitat Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23(27):6533–6539. http://www.ncbi.nlm.nih.gov/pubmed/16116151. Accessed 26 Jan 2017 Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23(27):6533–6539. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​16116151. Accessed 26 Jan 2017
13.
Zurück zum Zitat Moschini M, Dell’ Oglio P, Luciano’ R, Gandaglia G, Soria F, Mattei A et al (2017) Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urol Oncol Semin Orig Investig 35(6):335–341CrossRef Moschini M, Dell’ Oglio P, Luciano’ R, Gandaglia G, Soria F, Mattei A et al (2017) Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urol Oncol Semin Orig Investig 35(6):335–341CrossRef
14.
Zurück zum Zitat Cai T, Tiscione D, Verze P, Pomara G, Racioppi M, Nesi G et al (2014) Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens. Urology 84(5):1141–1146. http://www.ncbi.nlm.nih.gov/pubmed/25239253. Accessed 21 Feb 2017 Cai T, Tiscione D, Verze P, Pomara G, Racioppi M, Nesi G et al (2014) Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens. Urology 84(5):1141–1146. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25239253. Accessed 21 Feb 2017
15.
Zurück zum Zitat Monn MF, Kaimakliotis HZ, Pedrosa JA, Cary KC, Bihrle R, Cheng L et al (2015) Contemporary bladder cancer: variant histology may be a significant driver of disease. Urol Oncol Semin Orig Investig 33(1):18.e15–18.e20CrossRef Monn MF, Kaimakliotis HZ, Pedrosa JA, Cary KC, Bihrle R, Cheng L et al (2015) Contemporary bladder cancer: variant histology may be a significant driver of disease. Urol Oncol Semin Orig Investig 33(1):18.e15–18.e20CrossRef
17.
Zurück zum Zitat Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A et al (2013) Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer 49(8):1889–1897. http://www.ncbi.nlm.nih.gov/pubmed/23466126. Accessed 21 Feb 2017 Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A et al (2013) Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer 49(8):1889–1897. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​23466126. Accessed 21 Feb 2017
20.
Zurück zum Zitat Montironi R, Cheng L, Scarpelli M, Lopez-Beltran A (2016) Pathology and genetics: tumours of the urinary system and male genital system: clinical implications of the 4th Edition of the WHO classification and beyond. Eur Urol 70(1):120–123CrossRefPubMed Montironi R, Cheng L, Scarpelli M, Lopez-Beltran A (2016) Pathology and genetics: tumours of the urinary system and male genital system: clinical implications of the 4th Edition of the WHO classification and beyond. Eur Urol 70(1):120–123CrossRefPubMed
21.
Zurück zum Zitat Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S (2014) Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol Semin Orig Investig 32(2):117–127. http://www.ncbi.nlm.nih.gov/pubmed/23477878. Accessed 20 Feb 2017 Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S (2014) Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol Semin Orig Investig 32(2):117–127. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​23477878. Accessed 20 Feb 2017
22.
Zurück zum Zitat Willis DL, Porten SP, Kamat AM (2013) Should histologic variants alter definitive treatment of bladder cancer? Curr Opin Urol 23(5):435–443CrossRefPubMed Willis DL, Porten SP, Kamat AM (2013) Should histologic variants alter definitive treatment of bladder cancer? Curr Opin Urol 23(5):435–443CrossRefPubMed
23.
Zurück zum Zitat Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y et al (2006) Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol 175(6):2048–2053. http://www.ncbi.nlm.nih.gov/pubmed/16697800. Accessed 10 Apr 2017 Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y et al (2006) Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol 175(6):2048–2053. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​16697800. Accessed 10 Apr 2017
24.
Zurück zum Zitat Rink M, Fajkovic H, Cha EK, Gupta A, Karakiewicz PI, Chun FK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61(4):854–855. http://www.ncbi.nlm.nih.gov/pubmed/22226583. Accessed 19 May 2016 Rink M, Fajkovic H, Cha EK, Gupta A, Karakiewicz PI, Chun FK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61(4):854–855. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​22226583. Accessed 19 May 2016
25.
Zurück zum Zitat Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O’Donnell MA et al (2009) The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 103(4):475–479. http://doi.wiley.com/10.1111/j.1464-410X.2008.08011.x. Accessed 28 Jan 2017 Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O’Donnell MA et al (2009) The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 103(4):475–479. http://​doi.​wiley.​com/​10.​1111/​j.​1464-410X.​2008.​08011.​x. Accessed 28 Jan 2017
28.
Metadaten
Titel
Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder
verfasst von
Mohammad Abufaraj
Shahrokh F. Shariat
Beat Foerster
Carmen Pozo
Marco Moschini
David D’Andrea
Romain Mathieu
Martin Susani
Anna K. Czech
Pierre I. Karakiewicz
Veronika Seebacher
Publikationsdatum
11.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 2/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-017-2116-3

Weitere Artikel der Ausgabe 2/2018

World Journal of Urology 2/2018 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.